Latest News
J&J Snack Foods: Strong Balance Sheet With Growing Dividends
J&J Snack Foods is rated BUY, supported by a 4% dividend yield, strong cash generation, and a net cash balance sheet. JJSF's stock trades at a 55% discount to recent peak EV/EBITDA multiples, reflecti

Trump-Xi Summit: 5 Issues To Watch And The Trading Playbook
Trump-Xi may extend the trade truce, but firm tariff cuts and timelines are needed to prevent a "sell the fact" reversal. Rare earth licences and AI chip rules are the key swing factors for USD/CNH, H
Cybertruck sales are running 94% below Elon Musk's original sales estimate
While Tesla (NASDAQ: TSLA) maintained electric vehicle (EV) market share dominance in the first half (H1) of 2026 with roughly 52.3%, its Cybertruck has been severely underperforming.
BBNX EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Beta Bionics (BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their Options If you purchased or acq
BZAI EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Blaize Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Blaize To Contact Him Directly To Discuss Their Options If you purchased or acquired
AI Is Coming For Consulting, But Accenture Is Fighting Back (Rating Downgrade)
Accenture plc remains undervalued, trading at a 24% discount to its $244 intrinsic value, and is rated a solid 'Buy.' AI poses risks to consulting revenue and pricing, but ACN's partnerships with Goog
DVLT EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Datavault AI Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Datavault AI To Contact Him Directly To Discuss Their Options If you purchased or acq
Walmart, Target and Costco Forecast: Retail Stocks Face Key Tests
Walmart and Target show potential recovery setups while Costco approaches a key earnings catalyst.

Gemini: Crypto Boost Ignored
Gemini Space Station, Inc. is set for a bullish rally as crypto prices rebound and business prospects improve. GEMI's services and non-exchange revenues are surging, offsetting exchange revenue declin

Cybin Inc. (HELP) Shareholder/Analyst Call Prepared Remarks Transcript
Cybin Inc. (HELP) Shareholder/Analyst Call Prepared Remarks Transcript
BrandPilot AI Announces Closing of Upsized Non-Brokered Private Placement and Proposed Debt Settlement
Toronto, Ontario--(Newsfile Corp. - September 22, 2026) - BrandPilot AI Inc. (CSE: BPAI) (OTCQB: BPAIF) (FSE: 8LH0) ("BrandPilot" or the "Company"), a performance marketing technology company focused
SuperCom Expands into 21st New U.S. State with New Electronic Monitoring Contract in Indiana
Community Corrections Agency Selects SuperCom's PureOne GPS Solution Following Field Evaluation for Adult and Juvenile Programs Incumbent Vendor Displaced NEW YORK, Sept. 22, 2026 /PRNewswire/ -- Supe
SHAREHOLDER REMINDER: Berger Montague Reminds Capricor Therapeutics, Inc. (CAPR) Investors of the September 28, 2026 Deadline
Philadelphia, Pennsylvania--(Newsfile Corp. - September 22, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR)
Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Exclusive worldwide agreement adds human cellular validation to Lunai's AI-driven Parkinson's workflow, connecting patient-derived subtypes with disease mechanisms, biomarkers and therapeutic targets
SPRY EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ARS Pharmaceuticals To Contact Him Directly To Discuss Their Options If you purchased
George Risk Industries: Small In Size, Strong In Performance
George Risk Industries remains a Buy, supported by compelling valuation, strong earnings growth, and a debt-free balance sheet. RSKIA reported Q1 net sales up 16.1% YoY, with a notable backlog in heav
For Real Diversification, Consider This Commodities ETF
Helped by fresh demand drivers from the world of artificial intelligence (AI), among other catalysts, there's ample talk that a new commodities supercycle is afoot. This could potentially give rise to

AI Optimism Returns, Pushing Inflation Risks Into The Background
Investors appeared poised to refocus on rising interest rates last week and related fallout for stocks. Yesterday's catalyst centered on Meta and its new Muse AI agent, which could reshape the enterpr
Clorox: The Fundamentals Are Deteriorating - The Dividends Won't Save You
Clorox is downgraded from hold to sell due to deteriorating fundamentals and unsustainable dividend coverage. Organic sales declined 13% in Q4 despite the GOJO acquisition, with only the international
Holland America Line Unveils New Beach Club and Food Pavilion at RelaxAway, Half Moon Cay
Guests will experience enhancements on more than two dozen Caribbean itineraries in advance of RelaxAway, Half Moon Cay's 30th anniversary celebration in 2027 Key Highlights: Holland America Line is